C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer

A. Nebbioso, V. Carafa, M. Conte, F.P. Tambaro, A. Ciro, J. Martens, M. Nees, R. Benedetti, I. Pallavicini, S. Minucci, G. Garcia-Manero, F. Iovino, G. Lania, C. Ingenito, V.B. Petrizzi, H.G. Stunnenberg, L. Altucci

Research output: Contribution to journalArticlepeer-review

Cite this